Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...
Craniofacial pain is among the most common chronic pain conditions, affecting more than one-fifth of the U.S. population 1. With this milestone, Curonix advances its mission to drive full-body PNS ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved for whole-body MRI-conditional use.
SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT ® PNS that will be presented at the ...
Please provide your email address to receive an email when new articles are posted on . Published results showed percutaneous peripheral nerve stimulation may provide clinically meaningful and ...
Please provide your email address to receive an email when new articles are posted on . Patients used the device for 60 days, and effects persisted for 6 months. 71% of patients reported improved Neck ...
Centennial Spine and Pain joined us at the New Mexico Living studio on Monday for our weekly health segment. This week, Dr. John Watkins told us all about peripheral nerve stimulators – what they are, ...
POMPANO BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company specializing in relieving chronic pain without the use of opioids, is proud to announce the ...
Advancements in medical technology are rapidly moving forward to further enhance diagnosis and treatment of various diseases. Engineers at the University of California in Berkeley develops the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results